FDA Greenlights CAR T Therapy for Large B-Cell Lymphoma – Specialty Pharmacy Times
|
FDA Greenlights CAR T Therapy for Large B-Cell Lymphoma
Specialty Pharmacy Times Officials with the FDA have expanded the approval for the chimeric antigen receptor (CAR) T-cell therapy tisagenlecleucel (Kymriah, Novartis) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after 2 or more lines of … |
